Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New types of plans target cultural and ethnic communities with special offerings and native-language practitioners.
In 2018, Black and Latino patients with advanced cirrhosis had a higher risk of mortality compared with white people.
However, liver cancer mortality has risen for both Latino men and women.
Testing is a fundamental step toward treating hepatitis C, yet many Latino Americans are not being screened.
Compared with Asians, other racial and ethnic groups were less likely to receive adequate HBV evaluation and treatment.
Early detection and adopting healthier lifestyles are critical to minimize long-term liver damage.
Patient satisfaction surveys fail to ask whether the patients experienced discrimination or received culturally competent care.
Second- and third-generation individuals in Los Angeles had a 35% and 61% higher risk, respectively, than those born in Mexico.
A study found that only 43% of clinical trials reported race and ethnicity. The FDA issued guidance to address these inequalities.
HIV advocates cheer: “In many ways, this is a very bold budget.” But they also call for a strategic national PrEP program.
“Over 40% of the vulnerable population in the U.S. lives within 5 miles of a CVS Pharmacy location, so we have a chance to engage them.”
COVID-19 had an “immense impact” on HIV, hepatitis and STI screening, prevention and care.
Latino individuals are at higher risk for NAFLD, but Black people with NAFLD are more likely to develop cirrhosis.
Reaching these three goals will help New York City eliminate viral hepatitis as a public health threat.
News and tweets from the SYNChronicity 2021 Conference on HIV, hepatitis C, sexually transmitted infections and LGBTQ health
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.